References
- D’AmicoAVChenMHRenshawAALoffredoMKantoffPWAndrogen suppression and radiation vs radiation alone for prostate cancer: a randomized trialJAMA2008299328929518212313
- BollaMHannoun-LeviJMFerreroJMConcurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: preliminary results of a multicentre phase II trialRadiother Oncol201097231231720846737
- MarshallDTRameySGolshayanARKeaneTEKraftASChaudharyUPhase I trial of weekly docetaxel, total androgen blockade, and image-guided intensity-modulated radiotherapy for localized high-risk prostate adenocarcinomaClin Genitourin Cancer2014122808624378335
- RedpathJLSunCSensitivity of a human hybrid cell line (HeLa X skin fibroblast) to radiation-induced neoplastic transformation in G2, M, and mid-G1 phases of the cell cycleRadiat Res199012122062112305039
- ArmstrongCMGaoACDrug resistance in castration resistant prostate cancer: resistance mechanisms and emerging treatment strategiesAm J Clin Exp Urol201532647626309896
- BissettDSetanoiansACassidyJPhase I and pharmacokinetic study of taxotere (RP 56,976) administered as a 24-hour infusionCancer Res19935335235278093854
- CouleaudPMorosiniVFrochotCRicheterSRaehmLDurandJOSilica-based nanoparticles for photodynamic therapy applicationsNanoscale2010271083109520648332
- RetifPPinelSToussaintMNanoparticles for radiation therapy enhancement: the key parametersTheranostics2015591030104426155318
- MirjoletCPapaALCrehangeGThe radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: a proof-of-conceptRadiother Oncol2013108113614223647757
- PapaALBoudonJBellatVDispersion of titanate nanotubes for nanomedicine: comparison of PEI and PEG nanohybridsDalton Trans201544273974625408156
- KasugaTHiramatsuMHosonASekinoTNiiharaKTitania nanotubes prepared by chemical processingAdv Mat1999111513071311
- PapaALMauriziLVandrouxDWalkerPMillotNSynthesis of titanate nanotubes directly coated with USPIO in hydrothermal conditions: a new detectable nanocarrierJ Phys Chem C2011115391901219017
- ParisJBernhardYBoudonJHeintzOMillotNDecreauRAPhthalocyanine-titanate nanotubes: a promising nanocarrier detectable by optical imaging in the so-called imaging windowRSC Adv20155963156322
- PontónPId’AlmeidaJRMMarinkovicBAThe effects of the chemical composition of titanate nanotubes and solvent type on 3-aminopropyltriethoxysilane grafting efficiencyApp Surf Sci2014301315322
- MirjoletJFBarberi-HeyobMMerlinJLThymidylate synthase expression and activity: relation to S-phase parameters and 5-fluorouracil sensitivityBr J Cancer199878162689662252
- LoiseauABoudonJMirjoletCCréhangeGMillotNTaxane-grafted metal-oxide nanoparticles as a new theranostic tool against cancer: the promising example of docetaxel-functionalized titanate nanotubes in preclinical development on prostate tumorsAdv Healthc Mater Epub2017518
- CooperBTSanfilippoNJConcurrent chemoradiation for high-risk prostate cancerWorld J Clin Oncol201564354226266099
- FizaziKFaivreLLesaunierFAndrogen deprivation therapy plus docetaxel and estramustine vs androgen deprivation therapy alone for high-risk localized prostate cancer (GETUG 12): a phase 3 randomized controlled trialLancet Oncol201516778779426028518
- RosenthalSAHuntDSartorAOA phase 3 trial of 2 years of androgen suppression and radiation therapy with or without adjuvant chemotherapy for high-risk prostate cancer: final results of radiation therapy oncology group phase 3 randomized trial NRG oncology RTOG 9902Int J Radiat Oncol Biol Phys201593229430226209502
- ZhuYLiuCArmstrongCLouWSandherAGaoACAntiandrogens inhibit ABCB1 efflux and ATPase activity and reverse docetaxel resistance in advanced prostate cancerClin Cancer Res201521184133414225995342
- KumarRBelzJMarkovicSNanoparticle-based brachytherapy spacers for delivery of localized combined chemoradiation therapyInt J Radiat Oncol Biol Phys201591239340025636762
- HrkachJVon HoffDMukkaram AliMPreclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profileSci Transl Med20124128128ra39
- BoudonJPapaALParisJMillotNTitanate nanotubes as a versatile platform for nanomedicineSeifalianADe MelAKalaskarDMNanomedicine2014403427
- SchuemannJBerbecoRChithraniDBRoadmap to Clinical use of gold nanoparticles for radiation sensitizationInt J Radiat Oncol Biol Phys201694118920526700713
- QuivrinMLoffroyRCormierLMultiparametric MRI and post implant CT-based dosimetry after prostate brachytherapy with iodine seeds: The higher the dose to the dominant index lesion, the lower the PSA bounceRadiother Oncol2015117225826126324019